Achiko creates new innovations in healthcare technology
Mackay, Ian M. (2020): The Swiss Cheese Respiratory Virus Defence. figshare. Figure. https://doi.org/10.6084/m9.figshare.13082618.v21
A multi-faceted, multi-layered (Swiss Cheese) approach is needed for managing Covid-19 and achieving virus control, particularly as the virus is projected to become endemic. Together with social distancing, mask wearing, hand hygiene and vaccine implementation, testing will continue to play an increasingly important role particularly as testing moves from reactive to proactive in nature.
Achiko provides a mobile telehealth and digital passporting service for the management of Covid-19, to enable people to integrate safely and confidently back into their daily lives.
Diagnostic testing is achieved with AptameX (formerly Project Gumnuts), a non-invasive DNA aptamer technology for the detection of Covid-19 that can be applied to an array of test kits and assay formats. Beyond Covid-19, there are many applications of this technology for other pathogens and this will be an area of strategic focus for the company.
AptameX works in synergy with mobile app Teman Sehat (Health Buddy) to deliver a fast, affordable and accurate mobile digital passport for Covid-19 certification. Together, they deliver a user-friendly and easily accessible solution that lends itself to mass adoption, all of which are critical and valuable advantages when compared to other testing methods (including PCR and rapid Antigen tests) and other mobile apps, providing a way for populations of people to be tested on an everyday basis. We seek to build a global footprint by securing licensing partnerships around the world.
Headquartered in Zurich, our entrepreneurial and multidisciplinary team have developed and commercialised leading innovations in biotechnology in many different markets.
Achiko is an international company, specialising in research innovation, biotechnology, healthcare and mobile application development, stemming from Switzerland, Spain, Southeast Asia and Australia.
Achiko AG is listed on the SIX Swiss Exchange
SWX: ACHI, ISIN CH0522213468